ArticleScientific reports2016

Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Cancer.

Jing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.